These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10573581)

  • 1. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Weber L; Poulsen HS; Hertz H; Müller J
    Med Pediatr Oncol; 1999 Dec; 33(6):564-71. PubMed ID: 10573581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Horm Res; 2000; 54(2):53-9. PubMed ID: 11251367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
    Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
    J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.
    Follin C; Erfurth EM
    Curr Treat Options Oncol; 2016 Sep; 17(9):50. PubMed ID: 27476159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
    van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late endocrine sequelae after radiotherapy of pediatric brain tumors are independent of tumor location.
    Rohrer TR; Beck JD; Grabenbauer GG; Fahlbusch R; Buchfelder M; Dörr HG
    J Endocrinol Invest; 2009 Apr; 32(4):294-7. PubMed ID: 19636193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose-volume effects on growth hormone secretion.
    Merchant TE; Goloubeva O; Pritchard DL; Gaber MW; Xiong X; Danish RK; Lustig RH
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1264-70. PubMed ID: 11955738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth.
    Brauner R; Rappaport R; Prevot C; Czernichow P; Zucker JM; Bataini P; Lemerle J; Sarrazin D; Guyda HJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):346-51. PubMed ID: 2645307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Predictive Value of Insulin-Like Growth Factor 1 in Irradiation-Dependent Growth Hormone Deficiency in Childhood Cancer Survivors.
    Cattoni A; Clarke E; Albanese A
    Horm Res Paediatr; 2018; 90(5):314-325. PubMed ID: 30645996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
    Beckers D; Thomas M; Jamart J; Francois I; Maes M; Lebrethon MC; De Waele K; Tenoutasse S; De Schepper J
    Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auxologic and biochemical characterization of the three phases of growth failure in pediatric patients with brain tumors.
    Meacham LR; Mason PW; Sullivan KM
    J Pediatr Endocrinol Metab; 2004 May; 17(5):711-7. PubMed ID: 15237704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation.
    Tillmann V; Shalet SM; Price DA; Wales JK; Pennells L; Soden J; Gill MS; Whatmore AJ; Clayton PE
    Horm Res; 1998; 50(2):71-7. PubMed ID: 9701699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
    Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
    J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
    Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.